NOVO-OGARYOVO, April 1. /TASS/. Russia will complete pre-clinical trials of the vaccines against the novel coronavirus (COVID-19) developed at the Ve·tor State Research Center of Virology and ...

Russian Venture Company Biofund, a Russian-based investment firm, and Quintiles, the world's leading biopharmaceutical services company, today announced a definitive agreement to support expansion of ...

Quintiles is partnering with a Russian investment fund to create new companies doing clinical trial work in the Russian Federation. No financial terms of the definitive agreement with Russian Venture ...

, an established clinical research organization providing clinical development services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced ...